Trials / Sponsors / scPharmaceuticals, Inc.

scPharmaceuticals, Inc.

Industry · 9 registered clinical trials.

Status	Trial	Phase	Started
Completed	Pharmacokinetics and Pharmacodynamics of Subcutaneous vs Intravenous Furosemide in Healthy Volunteers Heart Failure, Fluid Overload	Phase 1	2024-04-19
Completed	Avoiding Treatment in the Hospital With Furoscix for the Management of Congestion in Heart Failure - A Pilot S Heart Failure	Phase 2	2021-05-03
Completed	Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart Failure Heart Failure	Phase 3	2020-11-12
Completed	An Open Label Study to Evaluate the Impact of Duration of Subcutaneous Infusion of a Novel, pH Neutral Formula Healthy	Phase 1	2019-12-02
Completed	Product Design Clinical Performance Study of sc2Wear Furosemide Combination Product Heart Failure	Phase 3	2016-07-01
Completed	Pilot Study for First Clinical Use of sc2Wear Furosemide Combination Product Heart Failure	Phase 2	2016-07-01
Completed	Crossover Study to Compare the Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone Administration Pharmacokinetics in Healthy Adults	Phase 2 / Phase 3	2015-10-01
Completed	Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Heart Failure	Phase 2 / Phase 3	2015-04-01
Completed	Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration Heart Failure	Phase 1 / Phase 2	2014-12-01